Recent Progress in Prostate Cancer: Q&A With Johann S. de Bono, MD, PhD
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...
Category: AACR
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
In the fall issue, Cancer Today had the honor of highlighting two women whose cancer diagnoses led them to...
Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Paul Northcott, PhD, inaugural recipient of the AACR NextGen Grant for Transformative Cancer Research, has dedicated his research career...
Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference,...
Despite advances in treatment, nearly 1,800 children and adolescents in the U.S. die annually from cancer. In an article...
For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...